SCA
LH icon

Strathmore Capital Advisors’s Labcorp LH Stock Holding History

Strathmore Capital Advisors’s Portfolio LH Stock Details LH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$682K Sell
2,441
-125
-5% -$32.9K 0.18% 71
2026
Q1 		$677K Buy
2,566
+1
+0% +$271 0.19% 70
2025
Q4 		$644K Sell
2,565
-11
-0.4% -$2.92K 0.21% 61
2025
Q3 		$739K Sell
2,576
-176
-6% -$47.2K 0.3% 48
2025
Q2 		$713K Buy
+2,752
New +$670K 0.32% 46

Other funds holding LH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Strathmore Capital Advisors's LH Position: Q2 2026 in Review

Strathmore Capital Advisors reduced its Labcorp (LH) stake by 4.9% in Q2 2026, selling an estimated $32.9K and leaving 2,441 shares worth $682K. The position accounts for 0.18% of the portfolio, ranked #71.

Strathmore Capital Advisors first reported a position in LH in Q2 2025 and has held it in 5 quarters since. The position peaked at $739K in Q3 2025. 1,060 funds tracked by Wall St. Rank hold LH as of Q2 2026.

  • Strathmore Capital Advisors held 2,441 shares of Labcorp worth $682K as of Q2 2026.
  • Strathmore Capital Advisors sold 125 Labcorp shares in Q2 2026, an estimated $32.9K.
  • Labcorp made up 0.18% of Strathmore Capital Advisors's portfolio in Q2 2026, its #71 holding.
  • Strathmore Capital Advisors first reported a position in Labcorp in Q2 2025 and has held it in 5 quarters since.
  • Strathmore Capital Advisors's Labcorp position peaked at $739K in Q3 2025.
  • 1,060 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.

Based on Strathmore Capital Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.